ABCC9 and pulmonary arterial hypertension: As indicated in the Supplementary Table 1, our samples (lung, PAECs, PASMCs) used in the study were from control and PAH patients with different ages, so we did not exclude that these differences have any consequences on SUR2/Kir6.1 expression.